Barriers to Diverse Participation in Clinical Trials: Dr. Marya L. Shegog Explains [Video]

In this informative video, Dr. Marya L. Shegog, PhD, MPH, CHES, from the Lazarex Cancer Foundation in the San Francisco Bay Area, discusses the various barriers that prevent diverse populations from participating in clinical trials. While not an exhaustive list, Dr. Shegog highlights four key obstacles:

Lack of knowledge: Many individuals are simply unaware of the clinical trials available to them.
Cost: The expenses associated with participating in a clinical trial, including travel costs, can be prohibitive for many.

Stigma and myths: The misconception that participants will be treated like “lab rats” and other negative stereotypes surrounding clinical trials can deter people from getting involved.
Limited recruitment: Clinical trials often fail to actively recruit from minority populations, leading to a lack of diversity among participants.

Dr. Shegog emphasizes that these barriers are not the only ones but are some of the most significant challenges faced by diverse populations when it comes to accessing clinical trials.

The Lazarex Cancer Foundation is dedicated to breaking down these barriers and ensuring that everyone, regardless of their background, has the opportunity to participate in potentially life-saving clinical trials. To learn more about their work and how you can support their mission, please visit their website at https://lazarex.org/diversity-in-cancer-clinical-trials/

Share this video to help raise awareness about the obstacles preventing diverse participation in clinical trials and the importance of creating a more inclusive and accessible system for all.

#ClinicalTrialDiversity #HealthEquity #LazarexCancerFoundation #ClinicalTrialAccess #PatientAdvocacy